Skip to main content
. Author manuscript; available in PMC: 2020 Apr 20.
Published in final edited form as: J Pharmacokinet Pharmacodyn. 2018 Apr 27;45(4):557–575. doi: 10.1007/s10928-018-9585-x

Table 4.

Parameter estimates for acute phase response dynamics and blood lymphocyte count

Parameter (units) Definition Estimate (% CV)
Signal transducer and activator of transcription-3 mRNA and protein dynamics
kd,STAT3m (h−1) Degradation rate constant for STAT3 mRNA 0.33 (24.0)
SDRnSTAT3m(nM1) Stimulation constant for STAT3 mRNA synthesis 0.005 (10.9)
kd,STAT3 (h−1) Degradation rate constant for STAT3 protein 0.12 (22.3)
γSTAT3 Amplification factor for STAT3 protein 1.9 (9.3)
kSTAT3 (h−1) Phosphorylation/translocation rate constant 4.16 (fixed)
STAT3m (0) Baseline STAT3 mRNA 1 (fixed)
STAT3 (0) Baseline STAT3 protein 1 (fixed)
Serpin A1n and serpin A3 protein dynamics
kd,SerpinA3n (h−1) Degradation rate constant for serpin A3n 1.4 (fixed)
λ1 Power coefficient for pSTAT3N effect on serpin A3n 1.5 (17.5)
kd,SerpinA1 (h−1) Degradation rate constant for serpin A1 1.4 (fixed)
λ2 Power coefficient for pSTAT3N effect on serpin A1 0.6 (20.9)
 Serpin A3n (0) Baseline SerpinA3n protein 1 (fixed)
 Serpin A1 (0) Baseline SerpinA1 protein 1 (fixed)
Blood lymphocyte dynamics
kin (h−1) Trafficking rate constant for lymphocytes from tissue to blood 0.002 (14.3)
kout (h−1) Trafficking rate constant for lymphocytes from blood to tissue 0.23 (5.0)
IC50, MPL (ng/mL) Drug concentration inhibiting kin by 50% 6.15 (fixed)
kapoptosis (nM−1h−1) Second-order rate constant of LYMT apoptosis 0.0019 (72.6)
β1 Intrinsic efficiency of Serpin A1 1 (fixed)
β2 Intrinsic efficiency of Serpin A3n 1 (fixed)
LYMB (0) (K/uL) Baseline blood lymphocyte count 4.8 (fixed)
LYMT (0) (K/uL) Baseline tissue lymphocyte count 475.2 (fixed)